News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major economic data or central bank announcements were released in the past hour.
  • U.S. equity futures were largely unchanged amid a lack of fresh headlines.
  • Treasury yields traded with little movement as volumes remained low.
  • Oil and gold prices showed minimal change in the absence of new supply or demand shocks.
  • No major geopolitical developments or corporate filings were reported in the past hour.

Latest Articles

Enphase Energy Launches AI Assistant in the Enphase App, Bringing Agentic Intelligence to Home Energy Management

Enphase Energy Launches AI Assistant in the Enphase App, Bringing Agentic Intelligence to Home Energy Management

Enphase Energy has introduced the Enphase AI Assistant into its mobile app, offering homeowners an intelligent, AI-driven tool that provides personalized insights, explanations, and control over their home energy systems including solar, battery storage, EV charging, and grid interactions. This innovation aims to simplify energy management amidst i…

Twin Disc Announces Full Year and Fourth Quarter 2026 Results

Twin Disc Announces Full Year and Fourth Quarter 2026 Results

Twin Disc, Inc. announced its fiscal 2026 and Q4 results, showing an 11.9% full year sales increase to $381.3 million and an 18.3% increase for Q4, driven by Marine, Propulsion, Defense, and Land-Based Transmissions markets. The company improved net income to $27.1 million from a prior loss, enhanced EBITDA by 48%, and generated strong free cash fl…

ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa

ASP Isotopes Inc. (NASDAQ: ASPI) announced that Tetra4, its subsidiary Renergen Limited's developer of the Virginia Gas Project in South Africa, has commenced commissioning the Phase 1 Liquid Helium plant following engineering optimization. This new production source aims to alleviate global helium shortages with commercial production expected to s…

Adagene to Participate in Three Upcoming Investor Conferences

Adagene to Participate in Three Upcoming Investor Conferences

Adagene Inc., a clinical-stage biotechnology company specializing in antibody-based cancer immunotherapies, announced senior management will participate in three upcoming investor conferences in New York to present their latest clinical developments and strategic collaborations. The company highlighted its proprietary SAFEbody technology and lead c…

Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics announced that the FDA has granted Fast Track designation to their lead drug candidate, LTI-03, for treating idiopathic pulmonary fibrosis (IPF). LTI-03 is a novel, inhaled peptide therapy that aims to inhibit lung scarring and promote tissue repair. The company is actively enrolling patients in the Phase 2 RENEW clinical trial, w…

PowerCompute Announces July 2026 Production and Operational Update

PowerCompute Announces July 2026 Production and Operational Update

PowerCompute announced its July 2026 Bitcoin mining production totaled 7.9 BTC amid seasonal curtailments, generated $91,000 in energy sales revenue, maintained a Bitcoin treasury of over 315 BTC valued at $20.2 million, and refinanced $18 million of debt secured by its Bitcoin holdings, enabling use of Bitcoin as collateral instead of selling coin…

10x Genomics Upgraded - Turnaround Confirmed, Now Buy Atera Execution

10x Genomics Upgraded - Turnaround Confirmed, Now Buy Atera Execution

10x Genomics has moved from recovery to expansion: a successful product cycle around Atera plus improving margins and positive free cash flow make a tactical long worthwhile. I upgrade the stock to a buy for a long-term trade tied to Atera commercialization milestones, with an explicit entry, stop and target to manage execution risk.

NICE: Profitable AI Growth Underpriced — A 180-Day Trade Plan

NICE: Profitable AI Growth Underpriced — A 180-Day Trade Plan

NICE Ltd. combines profitable enterprise software with accelerating AI product adoption and a manageable valuation. Recent weakness from a near-term earnings miss has blown off some optimism; that creates a tradeable opportunity. We outline a long trade with entry at $101, stop at $92 and a $130 target, and explain the catalysts and risks that make…

Exyn Technologies Appoints Ben Williams as Interim Chief Executive Officer and Gregory McNeal as Chairman of the Board

Exyn Technologies Appoints Ben Williams as Interim Chief Executive Officer and Gregory McNeal as Chairman of the Board

Exyn Technologies has appointed Ben Williams as interim CEO and Gregory McNeal as Chairman of the Board following the resignation of the prior CEO. Both leaders bring extensive military and defense industry experience to drive the company's expansion into defense and national security sectors. The company emphasizes its advanced autonomous mapping …

Foresight and VisionWave Sign Strategic Cooperation Agreement to Advance AI-Enabled Autonomous Defense Systems

Foresight and VisionWave Sign Strategic Cooperation Agreement to Advance AI-Enabled Autonomous Defense Systems

Foresight Autonomous Holdings Ltd. and VisionWave Holdings, Inc. have entered a strategic cooperation agreement to develop advanced AI-enabled autonomous unmanned ground vehicles (UGVs) for defense applications. The collaboration combines Foresight's stereoscopic 3D perception and infrared sensing technology with VisionWave's VARAN™ autonomous UGV …

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics announced upcoming presentations at the European Society of Cardiology Congress highlighting positive topline results from the ACACIA-HCM Phase 3 trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy. The company plans to discuss these results with regulatory authorities and hosted an investor event to elabora…

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

Flyte, a subsidiary of Catheter Precision, Inc., announced surpassing 10,000 consumer accounts on its private aviation WebApp, with new account creation accelerating significantly in August 2026. The platform's user base spans 174 airports across 19 states, reflecting strong demand and effective customer acquisition through technology and strategic…

Advasa Holdings, Inc. Announces Revised Expected Trading Commencement Date for Common Stock on the Nasdaq Global Market

Advasa Holdings, Inc. Announces Revised Expected Trading Commencement Date for Common Stock on the Nasdaq Global Market

Advasa Holdings, Inc., a fintech payment holding company operating through its Japanese subsidiary, announced a revised date for the commencement of trading its common stock on the Nasdaq Global Market. Originally expected to begin on August 18, 2026, trading is now anticipated to start on August 25, 2026, to allow completion of standard administra…

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

Cerenome, Inc. announced new pharmacokinetic, dosimetry, safety, and activity data for its therapeutic REYOBIQ in leptomeningeal metastases patients, alongside economic analysis showing CNSide diagnostics can significantly reduce treatment costs. The data supports the company's integrated CNS oncology platform combining diagnostics, targeted therap…

BOS Reports Second Quarter and First Half 2026 Financial Results

BOS Reports Second Quarter and First Half 2026 Financial Results

BOS Better Online Solutions Ltd. reported a significant 29% year-over-year revenue increase in Q2 2026, driven by growth in its RFID division. Despite a soft first half revenue performance roughly matching last year, the company's strong backlog of $31 million and raised net income guidance reflect optimistic future prospects. BOS experienced curre…

InflaRx Announces Participation in September Investor Conferences

InflaRx Announces Participation in September Investor Conferences

InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapies targeting the complement system, announced its participation in two major investor conferences in September 2026. The company will deliver presentations and conduct investor meetings detailing advances in its lead programs, izicopan and vilobelimab, targeting C5a …

Autozi in Discussions with Multiple Investors for Approximately US$55 Million Follow-On Financing After Completing US$30 Million Investment to Accelerate Core Business Expansion

Autozi in Discussions with Multiple Investors for Approximately US$55 Million Follow-On Financing After Completing US$30 Million Investment to Accelerate Core Business Expansion

Autozi Internet Technology (Global) Ltd. announced ongoing discussions with multiple investors to secure approximately $55 million in additional financing following a recent $30 million investment. The funds will support the company's expansion in automotive supply-chain integration, development of cross-border platforms, enhancement of digital and…

Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2026

Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2026

Navios Maritime Partners L.P. reported record financial results for Q2 and H1 2026 with significant revenue and net income growth driven by higher charter rates and operational efficiency. The company declared a $0.06 quarterly distribution and announced a new $200 million common unit repurchase program. Fleet expansion continued with acquisitions …